Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function.
BACKGROUND
(1)H and (15)N transverse relaxation measurements on perdeuterated proteins are ideally suited for detecting backbone conformational fluctuations on the millisecond-microsecond timescale. The identification of conformational exchange on this timescale by measuring the relaxation of both (1)H and (15)N holds great promise for the elucidation of functionally relevant conformational changes in proteins.


RESULTS
We measured the transverse (1)H and (15)N relaxation rates of backbone amides of HIV-1 protease in its free and inhibitor-bound forms. An analysis of these rates, obtained as a function of the effective rotating frame field, provided information about the timescale of structural fluctuations in several regions of the protein. The flaps that cover the active site of the inhibitor-bound protein undergo significant changes of backbone (&phi;,psi) angles, on the 100 micros timescale, in the free protein. In addition, the intermonomer beta-sheet interface of the bound form, which from protease structure studies appears to be rigid, was found to fluctuate on the millisecond timescale.


CONCLUSIONS
We present a working model of the flap-opening mechanism in free HIV-1 protease which involves a transition from a semi-open to an open conformation that is facilitated by interaction of the Phe53 ring with the substrate. We also identify a surprising fluctuation of the beta-sheet intermonomer interface that suggests a structural requirement for maturation of the protease. Thus, slow conformational fluctuations identified by (1)H and (15)N transverse relaxation measurements can be related to the biological functions of proteins.
Ishima
R
R
Molecular Structural Biology Unit National Institute of Dental and Craniofacial Research National Institutes of Health Bethesda, MD 20892, USA.
Freedberg
D I
DI
Wang
Y X
YX
Louis
J M
JM
Torchia
D A
DA
D001381:Azepines; D019281:Dimerization; D016333:HIV Protease / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000737:chemistry* / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008958:Models, Molecular; D009154:Mutation; D009587:Nitrogen Isotopes; D011487:Protein Conformation; D014508:Urea / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism
D001381:Azepines; D017320:HIV Protease Inhibitors; D009587:Nitrogen Isotopes; D014508:Urea; D016333:HIV Protease; C085816:DMP 323